Page last updated: 2024-08-24

topotecan and Rhabdomyosarcoma 2

topotecan has been researched along with Rhabdomyosarcoma 2 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, JR; Arndt, CA; Donaldson, SS; Hawkins, DS; Lyden, ER; Morris, CD; Rodeberg, DA; Wolden, SL1
Armeanu-Ebinger, S; Bonin, M; Fuchs, J; Poths, S; Ruck, P; Seitz, G; Warmann, SW1
Breneman, J; Crist, W; Lyden, E; Meza, J; Pappo, AS; Teot, L; Vietti, T; Wiener, E1

Trials

2 trial(s) available for topotecan and Rhabdomyosarcoma 2

ArticleYear
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
    International journal of radiation oncology, biology, physics, 2015, Dec-01, Volume: 93, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Female; Humans; Infant; Lymph Nodes; Male; Meningeal Neoplasms; Radiotherapy Dosage; Retroperitoneal Neoplasms; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Topotecan; Treatment Failure; Tumor Burden; Vincristine

2015
Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-01, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Male; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Rate; Topotecan

2001

Other Studies

1 other study(ies) available for topotecan and Rhabdomyosarcoma 2

ArticleYear
Inhibition of glutathione-S-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma.
    International journal of oncology, 2010, Volume: 36, Issue:2

    Topics: Animals; Antineoplastic Agents; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gene Expression; Gene Expression Profiling; Glutathione Transferase; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Oligonucleotide Array Sequence Analysis; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Topotecan; Vincristine; Xenograft Model Antitumor Assays

2010